eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation, preventing thrombosis without an increased risk of bleeding.

Pharmaceutical

Biotechnology

eXIthera

eXIthera's headquarters in Westborough, MA, United States

Neil J. Hayward

Charles Victor Pollack Jr.

Andy Hu

Priya Jambhekar

Bert L. Chenard

Paula M. Bokesch

Frans L. Stassen

Frank Sellke

Paul Wotton

Jerrold Levy

Robert Ruffolo

Cornelius McKown Dyke

Afshin Ehsan

Jean M. Connors

Scott Yaphe

The Advisory and Director Team at eXIthera provides strategic guidance and oversight to ensure the company's focus on Factor XIa inhibition is effectively translated into groundbreaking anticoagulation therapies. The team integrates diverse expertise to drive innovation, regulatory compliance, and market success while maintaining the highest standards of patient safety.

Advisory and Director Team

This department focuses on strategic initiatives, partnerships, and regulatory compliance to drive business growth and clinical advancements.

Corporate Development

The Leadership Team at eXIthera drives the strategic vision and operational excellence of the company, focusing on advancing innovative therapies for anticoagulation through Factor XIa inhibition. They leverage their expertise in translational medicine and medical affairs to guide research initiatives, ensure regulatory compliance, and foster partnerships that enhance product development and market positioning.

Leadership Team

eXIthera

Org chart

Board & advisors

Teams

Advisory and Director Team

Corporate Development

Leadership Team

Offices

eXIthera

Org chart

Board & advisors

Teams

Advisory and Director Team

Corporate Development

Leadership Team

Offices

Related companies